Literature DB >> 12615865

Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan.

Katsutoshi Yamasaki1, Masaru Komatsu, Tomonari Yamashita, Koichi Shimakawa, Toshiro Ura, Hisaaki Nishio, Kaori Satoh, Ryoudou Washidu, Shohiro Kinoshita, Masanori Aihara.   

Abstract

The aim of this study was to research the distribution in the Kinki region of Japan of Enterobacteriaceae and Pseudomonas aeruginosa that produce extended-spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL). One thousand isolates, 200 of each of four enterobacterial species (i.e. Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae and Serratia marcescens) and 200 of P. aeruginosa, were collected from seven different laboratories during two 2 month periods, one in 1998 and one in 2000. A double-disc synergy test (DDST) and 2-mercaptopropionic acid inhibition test (2-MPAT) were used to confirm beta-lactamase-producing isolates. The DDST was positive for one isolate of E. coli, five of K. pneumoniae, two of E. cloacae and 14 of S. marcescens. The 2-MPAT was positive for five isolates of S. marcescens and two of P. aeruginosa. We identified the beta-lactamase type of each isolate by molecular confirmatory tests (isoelectric focusing, PCR and DNA sequencing): CTX-M-3 ESBLs (three isolates of K. pneumoniae, two of E. cloacae and 13 of S. marcescens), CTX-M-2 ESBL (one isolate of K. pneumoniae), SHV-12 ESBLs (one isolate of E. coli and one of S. marcescens), CTX-M-3 and SHV-12 combination ESBL (one isolate of K. pneumoniae) and IMP-1 MBLs (five isolates of S. marcescens and two of P. aeruginosa). In conclusion, many species of Gram-negative bacilli that produce CTX-M-3 ESBLs and IMP-1 MBLs were disseminated widely in different hospitals of the Kinki region of Japan. Therefore, monitoring of laboratory bacterial ecology seems important to stop the spread of these strains through nosocomial outbreaks.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615865     DOI: 10.1093/jac/dkg103

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  19 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.

Authors:  Neil Woodford; Anne T Eastaway; Michael Ford; Alistair Leanord; Chloe Keane; Reinhard M Quayle; Jane A Steer; Jiancheng Zhang; David M Livermore
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

3.  Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada.

Authors:  Baha Abdalhamid; Johann D D Pitout; Ellen S Moland; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan.

Authors:  Naohiro Shibata; Hiroshi Kurokawa; Yohei Doi; Tetsuya Yagi; Kunikazu Yamane; Jun-ichi Wachino; Satowa Suzuki; Kouji Kimura; Satoshi Ishikawa; Haru Kato; Yoshiyuki Ozawa; Keigo Shibayama; Kumiko Kai; Toshifumi Konda; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 5.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

6.  CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem.

Authors:  Claudia Mugnaioli; Francesco Luzzaro; Filomena De Luca; Gioconda Brigante; Mariagrazia Perilli; Gianfranco Amicosante; Stefania Stefani; Antonio Toniolo; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

7.  Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.

Authors:  Carole Moubareck; Ziad Daoud; Noha I Hakimé; Monzer Hamzé; Nicole Mangeney; Hiam Matta; Jacques E Mokhbat; Raymond Rohban; Dolla Karam Sarkis; Florence Doucet-Populaire
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 8.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

9.  Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Authors:  Lukasz Naumiuk; Anna Baraniak; Marek Gniadkowski; Beata Krawczyk; Bartosz Rybak; Ewa Sadowy; Alfred Samet; Józef Kur
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Study of CTX-M Type of Extended Spectrum β-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India.

Authors:  R Mohamudha Parveen; Subha Manivannan; B N Harish; S C Parija
Journal:  Indian J Microbiol       Date:  2011-01-25       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.